Semaglutide also slows gastric emptying, which is called gastric motility (how things move along and at what pace.) Slowed gastric emptying can lead to feelings of fullness, nausea, and sometimes vomiting too
Retatrutide , developed by Eli Lilly, is a novel triple agonist that simultaneously activates three receptors: GLP-1 (glucagon-like peptide-1) receptor reduces appetite and slows gastric emptying GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin secretion
If youre curious about which option is best for you, contact us today to schedule an appointment
Your body adjusts to the medication, and you may experience initial side effects like nausea that typically improve within the first two weeks
They are manufactured by the same company , come in the same dosing pen, and work identically in your body